1
This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama
Condition(s):Hepatitis A VaccineLast Updated:November 19, 2019Completed
HAVRIX: 74 Clinical Trials, Page 1 of 8
Hide Studies Not Open or Pending
2
Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals’ Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel
Condition(s):Hepatitis ALast Updated:March 2, 2018Withdrawn
3
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
Condition(s):Hepatitis ALast Updated:August 20, 2018Completed
4
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals’ Hepatitis A Vaccine, Havrix®
Condition(s):Hepatitis ALast Updated:November 18, 2015Withdrawn
5
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals’ Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals’ Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years
Condition(s):Infections, PapillomavirusLast Updated:July 20, 2015Withdrawn
6
Long-Term Immune Persistence of GlaxoSmithKline Biologicals’ Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Condition(s):Hepatitis ALast Updated:July 23, 2018Completed
7
Long-Term Immune Persistence of GlaxoSmithKline Biologicals’ Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Condition(s):Hepatitis ALast Updated:November 29, 2017Completed
8
Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine
Condition(s):Hepatitis ALast Updated:July 29, 2014Completed
9
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440
Condition(s):Japanese EncephalitisLast Updated:May 13, 2014Completed
10
A Study to Evaluate the Efficacy of GSK Biologicals’ Influenza Vaccine in Children
Condition(s):InfluenzaLast Updated:August 1, 2018Completed